FENTANYL TRANSDERMAL (DURAGESIC)

Course overview

FentaNYL transdermal is U.S. FDA-approved to treat persistent moderate/severe chronic pain in opioid-tolerant patients ≥ 2 years whose pain cannot be controlled by other drugs/means, AND who require long-term, continuous, around-the-clock administration. This continuing education module is designed to give the reader/learner an increased understanding of fentanyl transdermal. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.